Positron Emission Tomography/Computed Tomography (PET/CT)-Based, Local Consolidative Radiotherapy after Chemoimmunotherapy in Metastatic, Non-Oncogene-Addicted Non-Small-Cell Lung Cancer (NSCLC).
NSCLC 1
PET/CT 3
multimodal treatment 2
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
25 Apr 2023
25 Apr 2023
Historique:
received:
14
02
2023
revised:
12
04
2023
accepted:
17
04
2023
medline:
13
5
2023
pubmed:
13
5
2023
entrez:
13
5
2023
Statut:
epublish
Résumé
The optimal sequence of chemo/immuno- and radiotherapy (RT) in metastatic non-small-cell lung cancer (NSCLC) remains challenging. Here, we describe the case of a 58-year-old female patient with an initially metastasized NSCLC obtaining local and distance durable response after chemo-immunotherapy and local RT associated with immunotherapy maintenance. Our experience offers a valuable perspective in choosing how to combine therapies to ensure the longest possible response in patients with estimated poor prognosis.
Identifiants
pubmed: 37174930
pii: diagnostics13091538
doi: 10.3390/diagnostics13091538
pmc: PMC10177578
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cancers (Basel). 2020 Apr 23;12(4):
pubmed: 32340408
Clin Lung Cancer. 2022 Jul;23(5):e317-e320
pubmed: 35613998
J Thorac Oncol. 2018 Jun;13(6):831-839
pubmed: 29578107
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
J Immunother Cancer. 2020 Oct;8(2):
pubmed: 33051340
Cancers (Basel). 2022 Aug 17;14(16):
pubmed: 36010969
Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):170-177
pubmed: 31756415
Clin Lung Cancer. 2022 May;23(3):e269-e272
pubmed: 34470722
Lancet Respir Med. 2021 May;9(5):467-475
pubmed: 33096027
JAMA Oncol. 2018 Jan 11;4(1):e173501
pubmed: 28973074
Lancet Oncol. 2016 Dec;17(12):1672-1682
pubmed: 27789196
Cancer Med. 2021 Feb;10(4):1222-1239
pubmed: 33465302
J Thorac Oncol. 2019 Jul;14(7):1172-1183
pubmed: 31125736
Diagnostics (Basel). 2021 Nov 09;11(11):
pubmed: 34829420
Lancet Oncol. 2019 Jul;20(7):924-937
pubmed: 31122901
Lancet Oncol. 2017 Jul;18(7):895-903
pubmed: 28551359
J Thorac Oncol. 2018 Dec;13(12):1958-1961
pubmed: 30253974
JAMA Oncol. 2019 Sep 01;5(9):1276-1282
pubmed: 31294749
Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):225-226
pubmed: 32414625